Request for Nominations of Potential Reviewers To Serve on the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP), 2227-2228 [2019-01212]
Download as PDF
Federal Register / Vol. 84, No. 25 / Wednesday, February 6, 2019 / Notices
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)–RFA–TS–19–001,
Identify, Analyze and Evaluate Potential Risk
Factors for Amyotrophic Lateral Sclerosis
(ALS).
Date: April 24, 2019.
Time: 11:00 a.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Kimberly
Leeks, Ph.D., M.P.H., Scientific Review
Official, NCIPC, CDC, 4770 Buford Highway
NE, Mailstop F–63, Atlanta, Georgia 30341,
Telephone (770) 488–6562, KLeeks@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–01211 Filed 2–5–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
amozie on DSK3GDR082PROD with NOTICES1
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP) PAR13–129;
Amended Notice of Meeting
Notice is hereby given of a change in
the name of the Disease, Disability, and
Injury Prevention and Control Special
Emphasis Panel (SEP) PAR13–129;
February 26, 2019, 12:00 p.m.–4:00
p.m., EST which was published in the
Federal Register on December 21, 2018
Volume 83, Number 245, page 65675.
The meeting is being amended to
change the funding opportunity
announcement to PAR18–812.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
Nina Turner, Ph.D., Scientific Review
Officer, Office of Extramural Programs,
1095 Willowdale Road, Morgantown,
West Virginia 26506, Telephone: (304)
285–5976; Email: nxt2@cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
VerDate Sep<11>2014
18:09 Feb 05, 2019
Jkt 247001
2227
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
Request for Nominations of Potential
Reviewers To Serve on the Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)
[FR Doc. 2019–01206 Filed 2–5–19; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Notice of request for
nominations.
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)–DD19–002, The
Muscular Dystrophy Surveillance, Tracking,
and Research Network(MD STARnet).
Dates: April 2–3, 2019.
Times: 10:00 a.m.–6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman Ph.D., Scientific Review Officer, CDC,
4770 Buford Highway, Mailstop 80, Atlanta,
Georgia 30341, Telephone: (770) 488–6511,
kva5@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–01210 Filed 2–5–19; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
The Centers for Disease
Control and Prevention (CDC) is
soliciting nominations for possible
membership on the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP) in the
National Center for Injury Prevention
and Control (NCIPC), the National
Center for Environmental Health
(NCEH), and the Agency for Toxic
Substances and Disease Registry
(ATSDR).
SUMMARY:
Nominations for membership on
the NCIPC, NCEH and ATSDR SEPs
must be received no later than April 1,
2019. Packages received after this time
will not be considered for the current
membership cycle.
ADDRESSES: All nominations should be
mailed to NCIPC Extramural Program
Office (ERPO): Centers for Disease
Control and Prevention, 4770 Buford
Highway, Mailstop F–63, Atlanta, GA
30341, emailed (recommended) to
NCIPC_PeerReview@cdc.gov, or faxed to
(770) 488–4529.
FOR FURTHER INFORMATION CONTACT:
Kenneth Roberts, Public Health Analyst,
CDC/NCIPC/ERPO, 4770 Buford
Highway, Mailstop F–63, Atlanta, GA
30341; Telephone: (404) 498–1427;
Email: KRoberts3@cdc.gov.
SUPPLEMENTARY INFORMATION: The
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel provides advice and
guidance to the Secretary, Department
of Health and Human Services (HHS);
the Director, Centers for Disease Control
and Prevention (CDC), and the
Administrator, Agency for Toxic
Substances and Disease Registry
(ATSDR) regarding the concept review,
scientific and technical merit of grant
and cooperative agreement assistance
applications, and contract proposals
relating to the causes, prevention, and
control of diseases, disabilities, injuries,
and impairments of public health
significance; exposure to hazardous
substances in the environment; health
promotion and education; and other
related activities that promote health
and well-being. Nominations are being
DATES:
E:\FR\FM\06FEN1.SGM
06FEN1
amozie on DSK3GDR082PROD with NOTICES1
2228
Federal Register / Vol. 84, No. 25 / Wednesday, February 6, 2019 / Notices
sought for individuals who have
expertise and qualifications necessary to
contribute to the accomplishment of
NCIPC, NCEH and ATSDR SEP
objectives. Reviewers with expertise in
research for injury and violence
prevention are sought to serve on the
NCIPC SEPs, for research and evaluation
related, but not limited to the following
program fields: Child abuse and neglect,
opioid use disorder and overdose,
polysubstance use and impaired
driving, suicide/self-directed violence,
intimate partner violence, mechanisms
of injury and violence research, motor
vehicle injury, older adult falls, elder
maltreatment, sexual violence,
substance use and abuse, traumatic
brain injury, teen dating violence, and
youth violence related to NCIPC
research priorities (see www.cdc.gov/
injury/researchpriorities). Reviewers
with expertise in the following research
fields for prevention and reduction of
adverse effects related to environmental
hazards are sought to serve on the NCEH
and ATSDR SEPs for research and
evaluation related, but not limited to:
Amyotrophic Lateral Sclerosis (ALS),
perfluoroalkyl substances (PFAS)
contamination in drinking water,
environmental health, newborn
screening, environmental pollutants
(air/water), toxic substances most
commonly found at facilities on the
National Priorities List (NPL) (see
www.atsdr.cdc.gov/spl), chemical
releases, natural disasters, and other
potential NCEH or ATSDR research
priorities. In addition, reviewers with
expertise in the following general and
methodological fields are sought to
serve on the NCIPC, NCEH and ATSDR
SEPs: Economic evaluation,
epidemiology, etiology of disease,
community participatory research,
implementation and translation science,
intervention research, policy evaluation,
research evaluation, qualitative research
design, quantitative research design,
statistics, and surveillance.
Members and Chairs shall be selected
by the Secretary, HHS, or other official
to whom the authority has been
delegated, on an ‘‘as needed’’ basis in
response to specific applications being
reviewed with expertise to provide
advice. Members will be selected from
authorities in the various fields of
prevention and control of diseases,
disabilities, and injuries. Members of
other chartered HHS advisory
committees may serve on the panel if
their expertise is required.
Consideration is given to professional
training and background, points of view
represented, and upcoming applications
to be reviewed by the committee.
VerDate Sep<11>2014
18:09 Feb 05, 2019
Jkt 247001
Information about nominated
potential reviewers will be maintained
in the NCIPC Extramural Research
Program Office (ERPO) Scientific
Reviewer and Advisor Database. The
work of reviewers’ appointed to NCIPC,
NCEH and ATSDR SEPs includes the
initial review, discussion, and written
critique and evaluation of applications.
This work will enable the CDC/NCIPC,
NCEH and ATSDR to fulfill its mission
of funding meritorious research that
provides vital knowledge about
underlying risk and protective factors
and strategies for: Violence and injury
prevention (www.cdc.gov/injury), health
effects from exposures to environmental
agents and hazardous substances
(www.atsdr.cdc.gov), and the
environmental public health impact
caused by intentional or unintentional
events (www.cdc.gov/nceh).
The U.S. Department of Health and
Human Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. CDC reviewers
appointed to a SEP are not considered
Special Government Employees and
will not be required to file financial
disclosure reports.
Nominees interested in serving as a
potential reviewer on a SEP, CDC for
NCIPC, NCEH, or ATSDR programs
should submit the following items:
• Current curriculum vitae,
highlighting specific areas of research
interest and expertise as well as
complete contact information (name,
affiliation, mailing address, telephone
number, and email address).
Nomination materials must be
postmarked by April 1, 2019 and sent by
U.S. mail to: NCIPC Extramural
Research Program Office (ERPO):
Centers for Disease Control and
Prevention, 4770 Buford Highway,
Mailstop F–63, Atlanta, Georgia 30341
or to the ERPO electronic mailbox
NCIPC_PeerReview@cdc.gov.
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
PO 00000
Frm 00090
Fmt 4703
Sfmt 9990
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–01212 Filed 2–5–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC); Notice
of Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of charter renewal.
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Healthcare
Infection Control Practices Advisory
Committee, Department of Health and
Human Services, has been renewed for
a 2-year period through January 19,
2021.
SUMMARY:
Erin
Stone, M.A., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
CDC, 1600 Clifton Road NE, Mailstop
A–07, Atlanta, Georgia 30329–4027,
Telephone (404) 639–4045. Email;
hicpac@cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
FOR FURTHER INFORMATION CONTACT:
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–01207 Filed 2–5–19; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\06FEN1.SGM
06FEN1
Agencies
[Federal Register Volume 84, Number 25 (Wednesday, February 6, 2019)]
[Notices]
[Pages 2227-2228]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01212]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Potential Reviewers To Serve on the
Disease, Disability, and Injury Prevention and Control Special Emphasis
Panel (SEP)
ACTION: Notice of request for nominations.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
soliciting nominations for possible membership on the Disease,
Disability, and Injury Prevention and Control Special Emphasis Panel
(SEP) in the National Center for Injury Prevention and Control (NCIPC),
the National Center for Environmental Health (NCEH), and the Agency for
Toxic Substances and Disease Registry (ATSDR).
DATES: Nominations for membership on the NCIPC, NCEH and ATSDR SEPs
must be received no later than April 1, 2019. Packages received after
this time will not be considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to NCIPC Extramural Program
Office (ERPO): Centers for Disease Control and Prevention, 4770 Buford
Highway, Mailstop F-63, Atlanta, GA 30341, emailed (recommended) to
NCIPC_PeerReview@cdc.gov, or faxed to (770) 488-4529.
FOR FURTHER INFORMATION CONTACT: Kenneth Roberts, Public Health
Analyst, CDC/NCIPC/ERPO, 4770 Buford Highway, Mailstop F-63, Atlanta,
GA 30341; Telephone: (404) 498-1427; Email: KRoberts3@cdc.gov.
SUPPLEMENTARY INFORMATION: The Disease, Disability, and Injury
Prevention and Control Special Emphasis Panel provides advice and
guidance to the Secretary, Department of Health and Human Services
(HHS); the Director, Centers for Disease Control and Prevention (CDC),
and the Administrator, Agency for Toxic Substances and Disease Registry
(ATSDR) regarding the concept review, scientific and technical merit of
grant and cooperative agreement assistance applications, and contract
proposals relating to the causes, prevention, and control of diseases,
disabilities, injuries, and impairments of public health significance;
exposure to hazardous substances in the environment; health promotion
and education; and other related activities that promote health and
well-being. Nominations are being
[[Page 2228]]
sought for individuals who have expertise and qualifications necessary
to contribute to the accomplishment of NCIPC, NCEH and ATSDR SEP
objectives. Reviewers with expertise in research for injury and
violence prevention are sought to serve on the NCIPC SEPs, for research
and evaluation related, but not limited to the following program
fields: Child abuse and neglect, opioid use disorder and overdose,
polysubstance use and impaired driving, suicide/self-directed violence,
intimate partner violence, mechanisms of injury and violence research,
motor vehicle injury, older adult falls, elder maltreatment, sexual
violence, substance use and abuse, traumatic brain injury, teen dating
violence, and youth violence related to NCIPC research priorities (see
www.cdc.gov/injury/researchpriorities). Reviewers with expertise in the
following research fields for prevention and reduction of adverse
effects related to environmental hazards are sought to serve on the
NCEH and ATSDR SEPs for research and evaluation related, but not
limited to: Amyotrophic Lateral Sclerosis (ALS), perfluoroalkyl
substances (PFAS) contamination in drinking water, environmental
health, newborn screening, environmental pollutants (air/water), toxic
substances most commonly found at facilities on the National Priorities
List (NPL) (see www.atsdr.cdc.gov/spl), chemical releases, natural
disasters, and other potential NCEH or ATSDR research priorities. In
addition, reviewers with expertise in the following general and
methodological fields are sought to serve on the NCIPC, NCEH and ATSDR
SEPs: Economic evaluation, epidemiology, etiology of disease, community
participatory research, implementation and translation science,
intervention research, policy evaluation, research evaluation,
qualitative research design, quantitative research design, statistics,
and surveillance.
Members and Chairs shall be selected by the Secretary, HHS, or
other official to whom the authority has been delegated, on an ``as
needed'' basis in response to specific applications being reviewed with
expertise to provide advice. Members will be selected from authorities
in the various fields of prevention and control of diseases,
disabilities, and injuries. Members of other chartered HHS advisory
committees may serve on the panel if their expertise is required.
Consideration is given to professional training and background, points
of view represented, and upcoming applications to be reviewed by the
committee.
Information about nominated potential reviewers will be maintained
in the NCIPC Extramural Research Program Office (ERPO) Scientific
Reviewer and Advisor Database. The work of reviewers' appointed to
NCIPC, NCEH and ATSDR SEPs includes the initial review, discussion, and
written critique and evaluation of applications. This work will enable
the CDC/NCIPC, NCEH and ATSDR to fulfill its mission of funding
meritorious research that provides vital knowledge about underlying
risk and protective factors and strategies for: Violence and injury
prevention (www.cdc.gov/injury), health effects from exposures to
environmental agents and hazardous substances (www.atsdr.cdc.gov), and
the environmental public health impact caused by intentional or
unintentional events (www.cdc.gov/nceh).
The U.S. Department of Health and Human Services policy stipulates
that committee membership be balanced in terms of points of view
represented, and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens, and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. CDC reviewers
appointed to a SEP are not considered Special Government Employees and
will not be required to file financial disclosure reports.
Nominees interested in serving as a potential reviewer on a SEP,
CDC for NCIPC, NCEH, or ATSDR programs should submit the following
items:
Current curriculum vitae, highlighting specific areas of
research interest and expertise as well as complete contact information
(name, affiliation, mailing address, telephone number, and email
address).
Nomination materials must be postmarked by April 1, 2019 and sent
by U.S. mail to: NCIPC Extramural Research Program Office (ERPO):
Centers for Disease Control and Prevention, 4770 Buford Highway,
Mailstop F-63, Atlanta, Georgia 30341 or to the ERPO electronic mailbox
NCIPC_PeerReview@cdc.gov. Nominations may be submitted by the candidate
him- or herself, or by the person/organization recommending the
candidate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities for both CDC and the Agency for Toxic Substances
and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-01212 Filed 2-5-19; 8:45 am]
BILLING CODE 4163-18-P